Healthcare >> Analyst Interviews >> January 12, 2004


JAN DAVID WALD, Vice President, Securities Research, joined A.G. Edwards in June 2000 and focuses his research efforts in the medical technology industry. Dr. Wald is an active publisher of industry and company- specific research reports focused in the areas of cardiology and neurology. He has previous work experience in the medical technology industry, working at Guidant Corp. and Honeywell, Inc. At Guidant, Dr. Wald managed clinical programs as well as the development of the algorithms and software for two implantable defibrillators. He worked as a scientist and manager of image processing algorithm and robotics programs at Honeywell. Prior to joining A.G. Edwards, Dr. Wald was a Senior Vice President and Senior Analyst in medical technology at George K. Baum & Co. He has a PhD from Brandeis University and an MBA from the University of St. Thomas. Dr. Wald also holds a patent on atrial fibrillation detection. Profile
TWST: Can we start with a quick overview of your coverage?

Dr. Wald: We cover the large cap cardiology companies ' Medtronic (MDT),

Guidant (GDT), St. Jude (STJ), Boston Scientific (BSX). I